The landscape of dementia diagnosis has evolved significantly with the appearance of refined biomarkers, together with amyloid PET scans, tau imaging, and blood-primarily based assessments that can detect Alzheimer's pathology a long time in advance of signs and symptoms emerge. When these technological innovations signify impressive development in